OKYO Pharma Limited - American Depositary Shares — Cash Flow (NASDAQ:OKYO) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -5.47 M7.7 M9.5 M1.8 M — Cash from investing activities -1 669-5 9160-1 208 — Cash from financing activities 2.15 M9.32 M6.21 M2.66 M — Free cash flow -5.47 M7.7 M9.5 M1.8 M —

Haberler

Piper Sandler, OKYO Pharma hissesine Ağırlıklı Al önerisi verdi

Piper Sandler initiates OKYO Pharma stock with Overweight rating

OKYO Pharma hisseleri 20 milyon dolarlık halka arz duyurusuyla sert düştü

OKYO Pharma stock tumbles on $20 million public offering announcement

OKYO Pharma 20 milyon dolarlık adi hisse senedi halka arzını duyurdu

OKYO Pharma announces $20 million public offering of ordinary shares

OKYO Pharma ATM hisse senedi teklifini satış aracısı olarak Leerink Partners’a devretti

OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent

OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program

OKYO Pharma, urcosimod NCP çalışma sonuçlarını ASCRS toplantısında sunacak

OKYO Pharma to present urcosimod NCP study results at ASCRS meeting

H.C. Wainwright, OKYO Pharma hissesi için Al tavsiyesini 7 dolar hedef fiyatla yineledi